Clinical Trials

A random assigned trial for psilocybin or MDMA treatment of non-responsive Obsessive Compulsive Disorder. Participants in this trial have previously tried psychotherapy and medication to treat OCD with limited success. They are assessed for suitability, risk factors are assessed, and if deemed appropriate, they are then moved into the trial program. It is a blind trial so participants do not know if they are experiencing which medicine. Reports from around the world and early indications of this trial, suggest that this may be a novel new option in our treatment regime.